Funding is a core element of ERDERA’s strategy to transform rare disease research in Europe. Its mission is to bridge gaps in scientific knowledge, foster international collaborations, and deliver tangible benefits to millions of patients affected by rare diseases across Europe and beyond.
ERDERA Funding
By pooling resources from the regional/national funding agencies, the EC, the private sector organisations, and philanthropic foundations, ERDERA drives forward groundbreaking research that has the potential to transform lives.
ERDERA’s funding research strategy is built upon a diversity of calls: Joint Transnational Calls, Clinical Trial Calls and the Networking Support Scheme. The topics of these calls are selected by gap analysis according to the needs of the rare disease community gathered from the recommendations of the ERDERA’s advisory and governing bodies.
Joint Transnational Calls
Supports interdisciplinary research to address identified gaps. These calls foster cross-border collaboration and align with the strategic priorities of the rare disease community.
Plays a crucial role in building the research ecosystem by fostering knowledge sharing across national and international actors, attracting underrepresented regions, engaging young researchers, and strengthening the involvement of patient organisations.
Clinical Trial Call
Funds controlled clinical research studies undertaken in humans to establish or confirm the safety and effectiveness of therapeutic interventions. These will benefit from ERDERA support for regulatory and methodological aspects.
Active & Upcoming Calls
At ERDERA, Public and Patient Involvement and Engagement (PPIE) is a core part of how research is designed, governed, and funded. By involving patients and the public throughout the research process, ERDERA helps ensure that research is more relevant, inclusive, and responsive to real-world needs. PPIE is also an important consideration in the evaluation and selection of funded projects.
You might also be interested in
